Anti-GP1BB/ BDPLT1/ BS monoclonal antibody

Anti-GP1BB/ BDPLT1/ BS antibody for FACS & in-vivo assay

Target products collectionGo to GP1BB/GP1BB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0486-Ab-1/ GM-Tg-hg-MP0486-Ab-2Anti-Human GP1BB monoclonal antibodyHuman
GM-Tg-rg-MP0486-Ab-1/ GM-Tg-rg-MP0486-Ab-2Anti-Rat GP1BB monoclonal antibodyRat
GM-Tg-mg-MP0486-Ab-1/ GM-Tg-mg-MP0486-Ab-2Anti-Mouse GP1BB monoclonal antibodyMouse
GM-Tg-cynog-MP0486-Ab-1/ GM-Tg-cynog-MP0486-Ab-2Anti-Cynomolgus/ Rhesus macaque GP1BB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0486-Ab-1/ GM-Tg-felg-MP0486-Ab-2Anti-Feline GP1BB monoclonal antibodyFeline
GM-Tg-cang-MP0486-Ab-1/ GM-Tg-cang-MP0486-Ab-2Anti-Canine GP1BB monoclonal antibodyCanine
GM-Tg-bovg-MP0486-Ab-1/ GM-Tg-bovg-MP0486-Ab-2Anti-Bovine GP1BB monoclonal antibodyBovine
GM-Tg-equg-MP0486-Ab-1/ GM-Tg-equg-MP0486-Ab-2Anti-Equine GP1BB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0486-Ab-1/ GM-Tg-hg-MP0486-Ab-2; GM-Tg-rg-MP0486-Ab-1/ GM-Tg-rg-MP0486-Ab-2;
GM-Tg-mg-MP0486-Ab-1/ GM-Tg-mg-MP0486-Ab-2; GM-Tg-cynog-MP0486-Ab-1/ GM-Tg-cynog-MP0486-Ab-2;
GM-Tg-felg-MP0486-Ab-1/ GM-Tg-felg-MP0486-Ab-2; GM-Tg-cang-MP0486-Ab-1/ GM-Tg-cang-MP0486-Ab-2;
GM-Tg-bovg-MP0486-Ab-1/ GM-Tg-bovg-MP0486-Ab-2; GM-Tg-equg-MP0486-Ab-1/ GM-Tg-equg-MP0486-Ab-2
Products NameAnti-GP1BB monoclonal antibody
Formatmab
Target NameGP1BB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GP1BB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GP1BB/ BDPLT1/ BS VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004607human GP1BB Lentivirus plasmid
    ORF Viral VectorvGMLP004607human GP1BB Lentivirus particle
    ORF Viral VectorpGMLPm004622mouse Gp1bb Lentivirus plasmid
    ORF Viral VectorvGMLPm004622mouse Gp1bb Lentivirus particle


    Target information

    Target IDGM-MP0486
    Target NameGP1BB
    Gene ID2812,14724,116727,712129,100298963,111774801
    Gene Symbol and SynonymsBDPLT1,BS,CD42C,GP1BB,GPIBB,GPIbbeta
    Uniprot AccessionP13224,Q9JJM7
    Uniprot Entry NameGP1BB_HUMAN,GP1BB_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000203618
    Target ClassificationN/A

    The target: GP1BB, gene name: GP1BB, also named as BDPLT1, BS, CD42C, GPIBB, GPIbbeta. Platelet glycoprotein Ib (GPIb) is a heterodimeric transmembrane protein consisting of a disulfide-linked 140 kD alpha chain and 22 kD beta chain. It is part of the GPIb-V-IX system that constitutes the receptor for von Willebrand factor (VWF), and mediates platelet adhesion in the arterial circulation. GPIb alpha chain provides the VWF binding site, and GPIb beta contributes to surface expression of the receptor and participates in transmembrane signaling through phosphorylation of its intracellular domain. Mutations in the GPIb beta subunit have been associated with Bernard-Soulier syndrome, velocardiofacial syndrome and giant platelet disorder. The 206 amino acid precursor of GPIb beta is synthesized from a 1.0 kb mRNA expressed in plateletes and megakaryocytes. A 411 amino acid protein arising from a longer, unspliced transcript in endothelial cells has been described; however, the authenticity of this product has been questioned. Yet another less abundant GPIb beta mRNA species of 3.5 kb, expressed in nonhematopoietic tissues such as endothelium, brain and heart, was shown to result from inefficient usage of a non-consensus polyA signal in the neighboring upstream gene (SEPT5, septin 5). In the absence of polyadenylation from its own imperfect site, the SEPT5 gene produces read-through transcripts that use the consensus polyA signal of this gene. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.